Introduction
In the course of B cell differentiation the expression of surface Ig changes from the presence of only IgM on immature cells in the bone marrow to both IgM and IgD on the majority of mature, peripheral B lymphocytes. After B cell activation the level of IgD is down-regulated, accompanied by the production of secretory IgM. Changes in expression of these classes of Ig heavy chain have been largely attributed to alterations in synthesis of mRNA derived from the µ-δ gene complex. The regulation of this process is complicated by the requirement for alternative splicing of the assembled VDJ gene segment to exons encoding either µ or δ heavy chains (1) . In addition, alternative processing is involved in the synthesis of mRNA for the secretory (µS) or membrane (µM) forms of IgM. Based on the assumption that transcription termination would pre-empt alternative processing to downstream exons, we and others have extensively analyzed the nature of the primary transcripts at various stages of B cell sites that are differentially utilized during B cell differentiation and the effect of cis-regulatory sequences located within the gene complex in order to understand fully the regulatory factors for transcription termination.
In this study, we have utilized two mutant mouse strains to investigate the regulation of transcription termination within the µ-δ gene complex. The pµ.µδRatt strain harbors a transgene in which a 1160 bp µ-δ intergenic segment, termed att, is inverted. This segment contains the putative cis-regulatory region necessary for transcription termination upstream of the δ exons (20, 21) in immature B cells. In the µS -/-strain the µS exon, along with its polyadenylation site, has been deleted in the genomic DNA resulting in a complete deficit of secretory IgM production (22) . The deletion does not include the region containing a conotical binding site for MAZ, a zinc finger protein originally isolated by virtue of its binding to a site within the c-myc P2 promoter. Occupancy of this site has been postulated to cause DNA bending resulting in polymerase pausing (23) and therefore may participate in the regulation of termination within the µ-δ gene complex. The use of primary B cells provides the opportunity for examination of the possible additional effect of changes in extent of polymerase initiation during different stages of B cell differentiation. This difference (24, 25) , not detectable in tumor cells (26, 27) , may alter the ability of polymerases to recognize pause/termination sites. By transcription analysis of the µ-δ gene complex in these two strains we show that whereas both polyadenylation as well as cis-regulatory sequences are important for transcription termination, the mode of action of the sequences depends on the stage of B cell differentiation.
Because run-on transcription analyses of transfectants are cumbersome and sometimes results are difficult to interpret, we designed a novel method to assess transcription readthrough in an attempt to further limit the att site sequences. Using this method, we have identified a 200 bp segment from the att site that induces transcription termination as effectively as the entire full-length segment in early B lineage cells but not in mature B cells. Correspondingly we have also demonstrated B cell stage-specific proteins that bind to this gene segment.
Methods

Constructs
The pµ.µδ Ratt construct was derived from the Pµ (27) vector which contains an Igµ gene rearranged to the 17.2.25 V region, extending up to the XhoI site within the µ-δ intron, the polyoma virus early region and a modified histone gene. Into the XhoI site was ligated, in the reverse orientation, a 1160 bp XhoI-EcoRV fragment derived from the genomic intronic region between µMII and C1 followed by a 4600 bp EcoRVEcoRV fragment derived from pLLn5R (20) . This fragment contains genomic sequences starting from the remaining µ-δ intron up to and including the CH to C3 intron, and cDNA sequences from C3, δMI and δMII (a allotype). The fusion of the cDNA segment eliminates~6 kb from the genomic sequence including the δX and δS exons. Animals A SalII-BsaAI fragment (see Fig. 2A ) isolated from the pµ.µδRatt construct, devoid of plasmid sequences, was micro- injected into mouse oocytes of the CD-1 strain (Jackson Laboratories, Bar Harbor, ME) by the Microinjection Services of UTSW Medical Center. Offspring were typed for transgene insertion by Southern blot analysis of tail DNA utilizing a δM specific probe. Because of the insertion of cDNA sequences in the construct, genomic hybridizing fragments could be distinguished from fragments containing the transgene. Two of these animals, lines 4393 and 4399, successfully transmitted the gene to the offspring. B cells in these two lines displayed similar phenotypes. The founders were mated with C57BL/6 (Jackson Laboratories). Further typing of transgene in offspring of founder mice was performed by PCR amplification utilizing primers containing sequences from δMI (5Ј-GTGACAGCTACATG) and δMII (5Ј-AGACCACAGCATGCTT)
at Pennsylvania State University on February 23, 2013 http://intimm.oxfordjournals.org/ Downloaded from which amplified a 380 bp fragment from the transgene and a 600 bp fragment from the endogenous gene. The transgenic mouse line carrying a rearranged Ig heavy chain gene with µ and δ encoding regions in the genomic context 29) was obtained from Dr Christopher Goodnow (John Curtin School of Medical Research, Canberra, Australia) and bred to C57BL/6 mice in our facilities. Mice carrying the transgene were typed by FACS staining with δ a and µ a reagents as described below. The generation of the µS -/-mouse line (22) has been previously described.
Cell preparation and cell lines
Red blood cells in tail vein bleeds were lysed to prepare peripheral blood lymphocytes. T cells were depleted from splenocytes as previously described (25) . Preparation of bone marrow cells, splenic B cells and activation with lipopolysaccharide (LPS) were performed as described previously (21) . The TD-1.1 cell line is one of several clones that arose spontaneously in our laboratory from Whitlock-Witte long-term bone marrow cultures (30) . It has the phenotype of a pre-B cell in that the cells expressed B220 as well as µ mRNA, but neither intracellular nor cell surface IgM expression was detectable (T. Dang and D. Yuan, unpublished observations). Bine 4.8 is a pre-B cell tumor (31) . M12.4 cells is a mature B cells lymphoma (32) ; however, very low levels of δ mRNA is made in transfectants of unmutated µ-δ constructs (D. Yuan and P. W. Tucker, unpublished observations). J558L (33) is a plasmacytoma that can secrete copious amounts of IgM or IgG from transfected constructs.
In vitro 'run-on' analysis Nuclei were prepared from cells and nascent RNA was labeled for 15 min at 30°C as previously described (2) using 100 µCi of [α-32 P]UTP (3000 Ci/mol; ICN Radiochemicals, Irvine, CA) per sample. Following the labeling, RNA was extracted and hybridized at 42°C for 3 days to 5 µg of double-stranded DNA probes immobilized on nitrocellulose. Subsequently, the filters were washed, treated with RNase as previously described, and exposed to a PhosphorImager screen and quantified using the Imagequant software package (Molecular Dynamics, Sunnyvale, CA). After subtraction of background hybridization to vector alone, relative hybridization to each probe was divided by the size of the probe to assess relative polymerase loading on each gene segment.
Probes used for run-on analysis
Plasmid DNA containing gene fragments as previously described (25) and listed below were used for run-on analysis of bone marrow cells. This is possible because the DNA fragments introduced into mouse eggs contained no plasmid sequences, as evidenced by low hybridization to the control KS plasmid with no insert. (#1) The VD probe (21) is a 400 bp PCR product generated from the Pµ. vector and cloned into pBluescript II (KS, Stratagene, La Jolla, CA). (#2) The 5Ј C µ probe is a 550 bp TagI-PstI fragment from cDNA of MOPC 104 µ mRNA (34) containing part of C H 2, all of C H 3 and part of C H 4 subcloned into pGEM4 (Promega, Madison, WI). (#3)The 3Ј C µ probe is the adjoining 440 bp cDNA fragment containing part of C H 4, the µS exon up to the end of the µS processed mRNA subcloned into pGEM4. (#4) The µS-µM intronic probes is a 346 bp KpnIHaeIII genomic fragment subcloned into pGem2. (#5) The µMI probe is the adjoining 385 bp HaeIII-Pst1 genomic fragment subcloned into pGem 2. (#6) The µMII probe is the adjoining 330 bp PstII-HincII fragment genomic containing the µMII exon and all of the 3Ј untranslated region of µM mRNA subcloned into pGEM4. Because the µS -/-transgene contains a deletion of the intronic region between µS and µM and between the two µM exons, the value of the probe size used for normalization was reduced accordingly. (#7) The 5Ј att probe is a 345 bp XhoI-Pst1 genomic fragment, located in the µ-δ intron, subcloned into pGEM4. (#8) The 3Ј att probe is the adjoining 550 bp PstI-EcoRI genomic fragment subcloned into pGem 4. (#9) The C1-3 probe is a 764 bp fragment subcloned from TEPC 1017 cDNA into pUC 8 containing C1, δH and C3. (#10). The δM probe is a 710 bp HincII-BglII genomic fragment containing δM1 and δMII, subcloned into pGEM-2. Because the pµ.µδRatt transgene has a deletion of the MI-MII intron, the value of the probe size used for normalization was reduced accordingly. (#11) The GAPDH probe is a 1233 bp complete rat cDNA (35) cloned into KS. The C κ probe is a 482 bp HpaI-BglII genomic fragment including the C κ exon subcloned into pUC 8.
FACS
Peripheral blood lymphocytes or bone marrow cells were analyzed on the FACScan flow cytometer (Becton Dickinson, San Jose, CA) using reagents previously described (21) .
Plasmid construction for luciferase assay pGLIRES This vector was created by modification of the pGL3-basic (Promega, Madison, WI). The SalI site at 2010 was first destroyed before insertion of the internal ribosomal entry sites (IRES) from EMCV virus into the BglII-NcoI site. The IRES sequence (36, 37) was amplified from pCIN4 (Dr Stephen Rees, Glaxo Wellcome) with the primers 5Ј-CGAGCATA-GATCTAGGGCGGCGAATTCG-3Ј, incorporating BglII and EcoRI sites (underlined) and 5Ј-GGGGTTGTGCCATGGTTAT-CATCGTGTT-3Ј containing NcoI sites (underlined). pGLIgµ A 1084 bp DNA segment containing 460 bp 5Ј of µM I and extending 140 bp 5Ј of the µMII poly(A) signal was amplified from a vector containing the genomic sequences using the primers 5Ј-ACGCACGGGAATTCTGATCAAGAAAGT-3Ј, containing EcoRI site (underlined) and 5Ј-CATCAGAATTC-ACTGGTCGACTTCCAGT-3Ј incorporating EcoRI and SalI sites (underlined). The PCR product was digested with EcoRI and cloned into EcoRI site of PGLIRES to generate PGL3µM. The rearranged VDJ segment and IgH promoter region was then amplified from pµPoly (27) with the primers 5Ј-GGCGTAT-CAGAGGCCCT-3Ј which anneals to upstream of IgH promoter and 5Ј-GGTCAGTCTAGAAAGAAGACCATC-3Ј which anneals within µMII. The PCR product was digested with SalI and BclI and blunt-ended by Klenow fill-in and cloned into SmaI site of pGL3µM to generate pGLIgµ. pIgµfIVS or pIgµrIVS A1200 bp gene segment containing the µ-δ intronic sequences spanning the PstI site 3Ј of µMII up to 25 bp 5Ј of the C1 acceptor splice site was excised from the 
Transfection
Samples of 20 µg of test plasmid and 15 µg of pSVβ-galactosidase control plasmid were transient transfected together as previously described (38) . Transfected cells were assayed 24-48 h later.
Luciferase and β-galactosidase assays Luciferase activity was determined by using the Luciferase Assay Kit from Promega (Madison, WI) according to the manufacturer's instructions and measured with Optocomp luminometer (MGM Instrument). For the β-galactosidase assay, 100 µl of cell extract was diluted in 50 µl of 1ϫCell Lysis Buffer (Promega) and 150 µl of 2ϫAssay Buffer (0.2 M sodium phosphate buffer, pH 7.3, 2 mM MgCl 2 , 0.1 M β-mercaptoethanol, 1.33 mg/ml ONPG) was then added.
Reactions were incubated at 37°C until the absorbance could be read at 420 nm. Luciferase activity was normalized to β-galactosidase activity in each transfection to correct for transfection efficiency.
Nuclear extract preparation
Nuclear extracts from TD1.1 or J558L cells were prepared by slight modifications of previously described methods (39) .
Gel electrophoresis mobility shift assays DNA probes were either generated by restriction enzyme digestions of subclones of the 'IVS' region as indicated in Fig. 4 (B) or by PCR amplification from the plasmid template containing the relevant sequences. Oligonucleotides used to generate the PCR fragment for the EcoRI-AccI region were: forward primer 5Ј-CAGGGAAAGAACAGAATTCTG and reverse primer: 5Ј-ATAAGTGTAGACCTGTGACAC. These primers were in turn used to generate the F105 and F88 fragment by using two additional oligonucleotides located in the middle of the segment. These are: forward primer 5Ј-AATTGGATGATGAACCCTGA and reverse primer: 5Ј-CCA-GAGTCACCTCTATGT. Products of the appropriate size were isolated by agarose gel electrophoresis and 5Ј-end-labeled with [γ-32 P]ATP (4500 Ci/mmol) and T4 polynucleotide kinase. Binding reactions contained 20 mM HEPES (pH 7.9), 0.2 mM EDTA, 20% glycerol, 100 mM KCl, indicated amount of poly(dI)-poly(dC) heteropolymer (Pharmacia), 5 mM DTT and 10,000-100,000 c.p.m. of end-labeled probe. Reactions initiated by the addition of protein were incubated for 30 min at 23°C. Protein-DNA complexes were resolved by PAGE containing 90 mM Tris-borate (pH 8.3), 2 mM EDTA and 2% glycerol. The running buffer was the same as the gel buffer except that glycerol was omitted. Gels were dried and exposed to phosphorimaging screens.
Results
Expression of the Pµ.µδRatt transgene Previously, we had generated a mouse strain harboring a transgene in which an intervening segment termed att, for attenuation of transcription, located between the µM and C exons was deleted (21) . This deletion effectively allowed transcription read-through to the C genes in immature B cells which would otherwise have terminated (21) . However, in this line the expression of the transgenic µ gene was compromised for reasons which are still under investigation. The lack of allelic exclusion of endogenous Ig gene due to the absence of transgenic µ gene expression complicated transcription analysis of the transgene. Therefore we have now generated a second transgenic line in which the att region was replaced in the opposite orientation. Based on previous studies in transfected cell lines showing that the effect of the att region is mediated in an orientation-dependent manner (20) transcription termination should be also alleviated. The 4399 line, harboring the pµ.µδRatt construct, expresses transgenic IgM and therefore allelically excludes endogenous gene rearrangement ( Fig. 1) as evidenced by the absence of expression of IgM bearing the b allotype when it is crossed to C57BL/6 mice. Interestingly, however, the level of transgenic IgD expression was lower than that exhibited by non-transgenic littermates or a control transgenic line, MD-3, which harbors an unmutated µ-δ transgene (29) . In addition IgD expression cannot be detected in transgenic bone marrow cells. These results suggest that inversion of the att site may have adversely affected transcription read-through and/or processing to the δ exons.
Transcription analysis of the Pµ.µδRatt transgenic line
To determine if insertion of the att sequences in the opposite orientation eliminated the transcription termination that usually occurs in immature B cells, bone marrow B cells from the transgenic animals were examined by run-on transcription analysis (Fig. 2B) . Nuclei prepared from these cells were pulse labeled with [ 32 P]UTP for 15 min and the labeled RNA was hybridized to a series of probes spanning the µ-δ region. Because the transgene excluded gene rearrangement (Fig. 1 ) transcription can be assessed in the absence of endogenous gene expression. There is, therefore, a relatively high level of hybridization to the transgene-specific V region probe although the level is still lower than the extent of transcription across the C µ gene because of contributions from sterile transcription of non-rearranged genes in the pro-B and pre-B cell compartment (40, 41) . It is also possible that the sterile transcription may persists to variable extents in mature B cells of transgenic mice with extensive allelic exclusion. By normalizing the extent of hybridization to each probe to that of the C µ probe, it is possible to compare the relative level of hybridization to the C exons in this strain with that from the MD-3 strain which does not differ significantly from nontransgenic bone marrow cells (21) . Clearly in the 4399 line transcription termination was alleviated to a great extent, although not completely. These findings confirm in primary B cells our earlier data obtained from transfected tumor cells (20) showing that this intergenic segment has to be present in the appropriate orientation for transcription termination upstream of the C exons to occur.
The µS polyadenylation site induces transcription termination
We had previously observed that in activated B cells transcription termination occurs at a region significantly more upstream of that occurring in early B cells. The transcription profile obtained from day 4 LPS-activated splenic B cells from 4399 mice (Fig. 2C) shows that this alteration of the site of transcription termination is not compromised by the inversion of the att site. Termination of the majority of the transcripts in activated B cells occurs within the µMII exon. There also appears to be pausing of polymerases in regions immediately preceding this termination site. This profile does not differ from that found for LPS-activated non-transgenic B cells (Fig. 3C) . We had previously observed that the site of termination in activated B cells is variable depending on the state of activation (25) . Because of the preferential usage of the µS poly(A) site in activated B cells, however, it is not clear whether the termination is a consequence of this usage or whether activation of termination-inducing trans-regulatory factors, such as, for example, the MAZ protein, results in the use of the upstream poly(A) site by default. To distinguish between these possibilities, we sought to determine whether termination in the µM region occurs in B cells obtained from the µS -/-mouse strain which cannot utilize the µS poly(A) site because it has been deleted. It should be noted that the µM poly(A) site and immediate downstream regions were not disturbed, therefore the binding of possible termination factors to the template or nascent RNA that extends through this segment should not be affected. The transcription profile of non-stimulated splenocytes from these µS -/-mutant animals was similar to that of normal littermates (Fig. 3B and data not shown). Upon LPS activation the relative level of hybridization between the µMII probe (#6) versus the C µ probe (#2) did not change. In contrast, in LPS-activated cells from littermate controls there was a significant decrease in this ratio. Thus, the termination usually found within this region was much alleviated. Interestingly, the pronounced pausing of polymerases in the region defined by the µMI probe often found in non-transgenic B cells also occurred in the µS -/-strain despite the deletion of the µMI-µMII intron. Significantly, although polymerases fail to exit in the region defined by probe #6, the majority of the newly induced transcripts in the mutant still terminates in a more upstream region than that in resting B cells. The increase in relative hybrization to the C µ probe when the transcription profiles are normalized to the level of hybridization to the GAPDH probe provides an estimate of the extent of increase in polymerase initiation induced by B cell activation (Fig. 3B) . This increase was found to be the same for activated B cells from the µS -/-mutants and control animals (probe 11; Fig. 3C ) therefore the diminished level of termination in the region of the µMII exon cannot be attributed to a lower response of the mutant cells to LPS activation.
Luciferase assay to measure transcription termination efficiency
Despite the alleviation of transcription termination in bone marrow cells of animals harboring the Pµ.µδRatt transgene to a level that is approximately the same as in mature spleen cells (Fig. 2C ) the extent of processing of the transcripts to the C exons is not increased. Further analysis indicated that splicing of VDJ to the C1 exon is diminished even in mature B cells (manuscript in preparation). Correspondingly, no IgD ϩ cells can be detected in the bone marrow (Fig. 1B) and a significant fraction of peripheral B cells express only IgM in the absence of IgD (see Fig. 1A ). The alteration in processing cannot be attributed to deletion of part of the δ gene in the 3Ј end ( Fig. 2A) because this phenotype was not observed in the strain harboring the pµ.µδ∆att transgene which has an identical 3Ј configuration (21) . The disruption of downstream processing appears to be due to the mutation of the att insert, therefore it is necessary to further refine the limits of this cisregulatory element so that a change therein can be targeted exclusively to transcription termination.
IRES have been employed to produce polycistronic mRNAs in retroviral-mediated gene transfer systems (37) . Here we use IRES from the encephalomyocarditis virus genome, a member of the picornaviridae family of viruses (36, 37) , for efficient expression independent of the 5Ј cap site of transcripts. The strategy is to construct a series of transfection vectors that contain putative termination sites located upstream of an IRES element such that only read-through transcripts that extend into the luciferase gene can be translated by ribosomes that enter at the internal ribosome binding sites and produce luciferase protein. In the absence of the luciferase promoter transcripts that terminate before the IRES will not extend to the coding sequence for the luciferase gene and no enzyme can be produced. In order to first test if the presence of IRES itself affects luciferase expression, we compared luciferase activity derived from the pGL3p control and the pGL3pIRES vector which has an IRES sequence inserted between the SV40 promoter and luciferase coding region. Figure 4(A) shows that in the presence of IRES (pGL3pIRES) luciferase expression in a plasmacytoma cell line (J558L) was decreased by 45-60% of that generated by direct transcription/translation from the SV40 promoter (pGL3p control). This level of decrease is not dissimilar to the effect of IRES shown previously in other systems (42, 43) and the signal intensity is still sufficient for use as a reporter system. We then substituted, for the SV40 promoter in pGL3pIRES, a gene segment that includes the Ig heavy chain promoter together with rearranged VDJ sequences as well as the µM coding region with intact poly(A) signal (pGLIgµ; Fig. 4B ).
To ascertain that the level of transcription read-through as measured by this method is similar to that measured by runon transcription analysis we first tested the effect of inserting the entire 1200 bp 'IVS' sequence previously shown to induce transcription termination (20) . The pIgµfIVS vector was transfected in parallel with control plasmid pGLIgµ and the relative luciferase activity derived from each plasmid was compared. Transcription of the µ-δ gene complex 821
Two cell lines representing two extreme ends of the B cell differentiation spectrum were transfected. The TD1.1 lymphoma cell line is derived from a pre-B cell culture and J558L is a plasmacytoma. Figure 4(C) shows that in TD1.1 cells luciferase activity derived from pIgµfIVS was Ͻ40% of that derived from the control plasmid, indicating that more than half of the polymerases that transited the µM region failed to reach the IRES and luciferase gene. However, in J558L cells the same fragment showed little effect on the abilities of polymerases to read through IRES and the luciferase gene. Moreover, transfection of pIgµrIVS, in which the 1200 bp 'IVS' segment was inserted in the reverse orientation, into either TD1.1 or J558L cells demonstrated comparable luciferase activity to that derived from the control plasmid in both cell lines showing that the termination efficiency of this segment is orientation dependent as described previously. These results are comparable to those from previous in vitro run-on analyses and confirm both the validity of the assay and the functionality of the terminator present in the µ-δ intronic region in the context of the IRES-luciferase construct.
Deletion analysis of the µ-δ intergenic region
In order to further delineate the elements required for regulation of termination, various fragments in the 'IVS' region were generated by restriction enzyme digestion and inserted into pGLIgµ and the effect of each fragment was assessed for termination efficiency. Figure 4(D) shows that luciferase expression from pIgµ3ЈIVS which contains the 3Ј half of 'IVS' region was decreased to 50% of that from pGLIgµ, while luciferase expression from pIgµ5ЈIVS which contains the 5Ј half of 'IVS' region did not differ from the control vector. These results suggest that the EcoRI-BglII fragment within the 'IVS' region plays an important role in transcription termination. This fragment was further bisected and cloned separately. Analysis of these two constructs, pGLIgµ3ЈX and pGLIgµ3ЈY, showed that the 5Ј half of active EcoRI-BglII fragment decreased luciferase activity as effectively as the entire fragment, whereas the 3Ј half did not significantly affect termination. Thus, these results demonstrate that essential elements for termination reside within the 200 bp fragment cloned into pGLIgµ3ЈIVS.
Protein binding to the fragment required for termination
To understand the mechanism by which termination may be dictated by the 182 bp EcoRI-AccI fragment within the pGLIgµ3ЈIVS we assessed whether proteins could bind to it in a B cell stage-specific manner. This fragment was 5Ј-endlabeled with [γ-32 P]ATP and binding reactions were performed by incubating the probe with either TD1.1 or J558L nuclear extracts followed by analysis of DNA-protein complexes on a non-denaturing polyacrylamide gel. Complexes with two different mobilities were formed by nuclear extracts from TD1.1 cells but not by those from J558L cells (Fig. 5A) , whereas a control fragment derived from a gene segment located more upstream but still within the 'IVS' region yielded complexes of similar mobility when bound to nuclear extracts from either TD1.1 or J558L cells (Fig. 5B) . The complex C1 with slower mobility was derived from specific binding because of its susceptibility to competition by the specific competitor consisting of the unlabeled probe but not by a non-specific competitor (Fig. 5C) , whereas the complex with the faster mobility, C2, which appeared with greater variability, was competed away by both specific and non-specific competitors. Other representative cell lines at similar developmental stages were also screened for the binding activity. As shown in Fig. 5(D In addition we have screened a number of fragments contained within most of the µ-δ intervening region. (data not shown). Although complexes were detected with some of the fragments no outstanding differences were detectable between extracts from the TD1.1 versus that from J558L plasmacytoma cells. A number of other fragments yielded no detectable binding for either cell type.
In an effort to further localize the protein binding site we bisected the EcoRI-AccI fragment by PCR amplification using two sets of primers resulting in adjacent 5Ј 105 bp and 3Ј 88 bp fragments (F88 and F105). When each of these fragments was separately assessed, F88 fragment formed complexes resulting in four bands with extracts from TD1.1 cells. Only the band with the slowest mobility was concentration dependent and showed reproducible binding (Fig. 6A ) and could be effectively competed by the homologous unlabeled fragment (Fig. 6B) but to a much lesser extent by F105. The faster mobility bands were competed by both homologous and heterologous fragments. In contrast, labeled F105 exhibited much lower levels of binding activity for the same extract. Whether the strong binding to the 88 bp fragment can account for the total termination activity of the pGL3ЈIVSx vector still awaits further functional confirmation.
Discussion
The steps of RNA synthesis and subsequent processing are now viewed as occuring as part of a complex unit in which at Pennsylvania State University on February 23, 2013 http://intimm.oxfordjournals.org/ Downloaded from all the factors needed for 5Ј capping, splicing as well as polyadenylation continue to be associated with the polymerase until it is disengaged from the template at the termination site (44) (45) (46) . In this context, analysis of the expression of the murine µ-δ gene complex is not only complicated by the close proximity of the two genes expressed differentially at different stages of B cell development but also influenced by the differential usage of multiple polyadenylation sites during B cell development and subsequent activation. Analysis of constructs containing restricted segments of this gene complex has been further complicated by the tendency of many B cell tumors to utilize the more proximal µS poly(A) site regardless of the differentiation stage (20, (47) (48) (49) and/or terminate transcription in an apparently deregulated manner. The utilization of non-transformed B cells from transgenic mice has allowed us to overcome some of these difficulties. Analysis of LPS-activated B cells from the µS -/-mouse strain, in which the µS poly(A) site has been deleted, shows that a substantial degree of transcription termination within the µM region in activated B cells is alleviated. It is important to note that this change occurred in spite of the fact that the extent of B cell activation is not affected by the mutation; therefore any putative trans-regulatory factor(s) necessary for altering upstream termination must have been induced.
This observation is consistent with recent findings showing that an increase in abundance of the 64 kDa subunit of the cleavage stimulation factor, CstF64, in activated B cells may be an important (50) but not sole driving force (51) for the selection of the µS poly(A) site. Interestingly, the site of termination upon increased µS polyadenylation is located Ͼ2 kb downstream of the cleavage site. Therefore, despite the dependence on polyadenylation, this process cannot be classified as poly(A) directed (19) . In contrast, in repeated run-on transcription assays (25; see also Fig. 2D ), we have noted large variations in the extent of polymerase loading, which can often be much higher than that in the C µ region, in the probes encompassing the region upstream of the µM poly(A) site. Therefore it appears that there is a polymerase pause site just downstream of this region that causes variations in the extent of polymerase entrapment. The best candidate for this site is the conotical MAZ binding site (23) located 200 bp downstream of the µM poly(A) site within a region previously documented to be a polymerase unloading site in tumor cells (4, 52) . The termination of transcription close to a pause site located some distance from the polyadenylation site is consistent with a model whereby polymerase activates polyadenylation (46) by continued association with these processing factors (45) . The presence of the MAZ site may provide the specificity needed for targeting of the increased amount of functional CstF64 to the IgH gene.
Regardless of the possible involvement of the MAZ site in activated B cells, clearly this site is bypassed in mature, resting B cells so that the δ exons are transcribed. In contrast, analysis of the pµ.µδRatt strain shows that in the presence of the att site, which is located further downstream, in the appropriate orientation, is necessary for transcription termination in immature B cells. Much of the polymerase downloading is effectively prevented by the insertion of this intergenic segment in the wrong orientation. The data presented herein does not address the question of whether the µM poly(A) site is necessary for termination at this site in primary B cells although previous data in transfectants indicated a necessity for the site. However, recent studies in a new gene knockout mutant offer some insight into this question. The δ polypeptide chain has been shown to have the ability to completely replace µ chain function during early B cell development in the IgM -/-mouse (53) which harbors a deletion of the entire µ gene as well as the att sequence located upstream of the δ exons. Interestingly, in the µMT -/-mouse strain (54) in which only the µMI exon was replaced by a neo gene, the presence of the downstream δ gene does not replace µ gene function in early B cells. It appears, therefore, that the retention of the att sequence in this case effectively prevented transcription progression to the δ exons despite the presence of the strong poly(A) site used by the inserted neo gene transcript. IgD expression from the mutated chromosome can be found in mature B cells of heterozygous animals, showing that the effect of the termination site can be overcome upon B cell maturation. Hence even in the presence of a heterologous polyadenylation signal the att sequence can function as an attenuation site.
Using a novel assay for assessing transcription termination we have defined the minimal cis-regulatory sequences within the att region that mediate termination. This assay is much more sensitive than run-on transcription analysis because it does not rely upon measurement of hybridization signals derived from labeled nascent transcripts. By this means we have defined a 200 bp segment within the att region that can induce transcription termination which, in the genomic context, is located 1650 bp downstream of the µMII poly(A) site and 650 bp 5Ј of C1. Of special significance is the apparent differentiation stage specificity of the ability of this segment to dictate transcription termination. Thus, termination is registered only in tumor cells that represent the equivalent of immature B cells, whereas in the plasmacytoma line, J558L, representing more mature B cells, the segment does not affect polymerase transit. Because termination activity is based on comparison with relative read-through in the parental vector that also contains the µM poly(A) site, any termination directed by this site should not affect the read-out. For all of the vectors analyzed, the level of termination detected by this method is, however, still incomplete for reasons that are unclear. It is possible that there are further upstream as well as downstream elements not included in the construct that exert additional modulatory effects. Nevertheless, these results establish the sequences contained within the 200 bp EcoRI-AccI fragment as a minimum requirement for induction of termination.
The mechanism underlying the termination-inducing activity of the EcoRI-AccI fragment remains unclear. One clue is derived from the correlation of protein binding with the functional activity of the fragment. We have shown that nuclear extracts from transformed counterparts of early B cells can bind to this fragment, whereas much less activity is contained with extracts from more mature B cell equivalents. Furthermore, specific binding can be restricted further to a 88 bp sequence. A simplistic model would predict that the protein binding serves as a block to transcription read-through and this binding is altered upon B cell activation. Further characterization, including footprint analysis, will be necessary in order to show whether there is preferential binding to the coding strand. However, the orientation dependence of the effect on transcription suggests that the att sequence does not function by bending DNA as has been shown for MAZ (23) . Furthermore, from the transcription profile there is no evidence for the region to act as a strong pause site for polymerase. Finally, it is always important to bear in mind that in vitro assays performed in transformed B cells do not always correlate completely with in vivo mechanisms occuring in normal B cells.
In conclusion, the findings reported here allow us to present a comprehensive view of transcription across the µ-δ gene complex. In early B cells, the µM poly(A) site is preferentially utilized to produce cells expressing exclusively membrane IgM. Usage of this site does not induce significant transcription termination despite the presence of the MAZ site located immediately downstream. It is not until the att site located some 1650 bp downstream is encountered that polymerase downloading occurs. We had previously designated this region as an attenuation site (21) because, in contrast to a termination site, the recognition of the att site is reversibly regulated by B cell maturation such that to allow read-through to downstream C exons, the site must be bypassed. We have now further refined the limits of this att site. At the other end of the differentiation spectrum occurring upon B cell activation, transcription initiation of the IgH gene complex is increased. The corresponding increased loading of polymerases may augment the effectiveness of the MAZ site resulting in the accumulation of polymerases in the immediate upstream region. The enhanced cleavage of the newly induced transcripts at the µS poly(A) site due to the increase in the polyadenylation factor CstF64 must destablize the polymerases to an extent that results in the dissociation of the majority of the transcripts when they reach a relatively discrete site within the µM 3Ј-untranslated region.
